[Specific immunostimulation in the therapy of recurrent herpes simplex type I or II].
The results of a study on the efficacy and tolerability of an immunotherapy with viral inactivated products in comparison with the usual antivirals on patients affected with herpes simplex I or II, are presented. The very good results obtained with the vaccine concerning frequency, intensity and duration of relapses (67% of cases with complete absence of relapse) are in good relation with an active stimulation due to the drug on the cell-mediated component of the immunity response. The examined antivirals allow to obtain a significant decrease of the intensity and duration of the relapses without interfering in any way with the immunity system.
Veneroni
G
G
Ente Ospedaliero Ospedale Fatebenefratelli e Oftalmico, Servizio Immunoematologia e Trasfusionale, Milano.
Calixte
C
C
Bozzo Costa
E
E
Germogli
R
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D006558:Herpes Genitalis / Q000628:therapy*; D006560:Herpes Labialis / Q000628:therapy*; D006801:Humans; D007635:Keratitis, Dendritic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D018139:Simplexvirus / Q000276:immunology*; D014765:Viral Vaccines / Q000627:therapeutic use*
D014765:Viral Vaccines
L'immunostimolazione specifica nella terapia dell'herpes simplex di tipo I o II recidivante.